Send us Feedback

AMDL (ADL)
Analysis
Data
Financials
QUOTE AND NEWS
Radient Pharma's (RPC) AMDL Diagnostics Enters Exlusive Distribution Agreement with Grifols USA for Commercialization of DR-70 Onko-Sure(TM)
StreetInsider.com  Oct 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Radient+Pharma%27s+%28RPC%29+AMDL+Diagnostics+Enters+Exlusive+Distribution+Agreement+with+Grifols+USA+for+Commercialization+of+DR-70+Onko-Sure%28TM%29/5004343.html for the full...
AMDL Diagnostics, Inc. Enters Into Exclusive Distribution Agreement With Grifols USA, LLC to Advance Commercialization of DR-70 Onko-Sure(TM) Cancer Test
PR Newswire  Oct 8  Comment 
Radient Pharma Enters Into Distribution Agreement to Launch Sales of Onko-Sure(TM) IVD Cancer Test in Israel
PR Newswire  Oct 6  Comment 
TUSTIN, Calif., Oct. 6 /PRNewswire-FirstCall/ -- Radient Pharmaceuticals Corporation (NYSE - AMEX: RPC), a US-based pharmaceutical company, announced today through its wholly-owned subsidiary AMDL Diagnostics, Inc. (ADI), it has entered into a
Radient Pharma Changes Corporate Name and Ticker Symbol
PR Newswire  Sep 29  Comment 
TUSTIN, Calif., Sept. 29 /PRNewswire-FirstCall/ -- Radient Pharmaceuticals Corporation (NYSE Amex: RPC), (formerly AMDL, Inc.), a US-based integrated pharmaceutical company, announced today it has fully completed its corporate name change to Radient
AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US
PR Newswire  Sep 18  Comment 
TUSTIN, Calif., Sept. 18 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major assets in China, announced today its stockholders have approved by verbal consent the name change and rebranding of
Dementia Progress Predicted by Impairment in ADL (CME/CE)
MedPage Today  Sep 16  Comment 
Among patients diagnosed with mild cognitive impairment, those who have more trouble with activities of daily living are more likely to progress to dementia, a study found.
PC/104 cards for MIL STD 1553 and ARINC 429 avionics data buses from DDC chosen by ADL
Military & Aerospace Electronics  Aug 3  Comment 
BOHEMIA, N.Y., 4 Aug. 2009. Data bus experts at Advanced Digital Logic Inc. (ADL) in San Diego needed PC/104 and PC/104 Plus cards for applications that require MIL STD 1553 or ARINC 429 avionics data bus interfaces. They found their solution from...
Speculative Darlings
Penny Sleuth  Jun 15  Comment 
During the final stages of a bull market, speculative stocks often gain the most. Investors get used to everything rising -- a lot. They forget about “petty” things like earnings and put their money in the hottest lottery tickets...I...
Suggest other news sources for this topic
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 
more ▼WIKI ANALYSIS
 
ADL AT A GLANCE
 
 
 
 
 
 
 
 

AMDL is a pharmaceutical company with operations in Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), they are a vertically integrated pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The company employs over 490 people in the U.S. and China and their headquarter is in Tustin, California.

For the 12 months ended December 31, 2008, the Company demonstrated strong top-line growth and sales performance. Gross revenues increased over 124%, reaching just over $33.6 million compared to approximately $15 million for the same period in FY2007. The significant growth in revenues was due to an increase in sales of existing products in the growing China healthcare market, which included AMDL's best-selling human placenta extract (HPE)-based skin care product, Domperidone anti-emetic drug, and other high-quality ethical pharmaceutical products.




References

Retrieved from "http://www.wikinvest.com/stock/AMDL_(ADL)"
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki